Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
about
Antihyperlipidemic and antiperoxidative effect of Diasulin, a polyherbal formulation in alloxan induced hyperglycemic rats.Antihyperglycemic effect of Trigonella foenum-graecum (fenugreek) seed extract in alloxan-induced diabetic rats and its use in diabetes mellitus: a brief qualitative phytochemical and acute toxicity test on the extract.Effects of current therapeutic interventions on insulin resistance.The effect of cimetidine on tolbutamide kineticsIndobufen interacts with the sulphonylurea, glipizide, but not with the beta-adrenergic receptor antagonists, propranolol and atenolol.Oral hypoglycaemic agents.Effect of the hypoglycaemic drug (-)-AZ-DF-265 on ATP-sensitive potassium channels in rat pancreatic beta-cells.ABCC9/SUR2 in the brain: Implications for hippocampal sclerosis of aging and a potential therapeutic target.Gmelina arborea Roxb. (Family: Verbenaceae) Extract Upregulates the β-Cell Regeneration in STZ Induced Diabetic RatsPharmacokinetics and pharmacodynamics of the hydroxymetabolite of glimepiride (Amaryl) after intravenous administration.Sulfonylureas: a new look at old therapy.Treatment for childhood type 2 diabetes.In vitro and in vivo antidiabetic potential of extracts and a furostanol saponin from Balanites aegyptiaca.Evaluation of the antidiabetic and antilipaemic activities of the hydroalcoholic extract of phoenix dactylifera palm leaves and its fractions in alloxan-induced diabetic rats.Expression, purification, crystallization and preliminary X-ray analysis of 4-hydroxy-3-methyl-2-keto-pentanoate aldolase (asHPAL) from Arthrobacter simplex strain AKU 626Treatment of type I diabetes with a combination of glyburide and insulin.Improved effect of tolbutamide when given before food in patients on long-term therapy.JTT-608 restores impaired early insulin secretion in diabetic Goto-Kakizaki rats.Pharmacokinetic study on gastrointestinal absorption of insulinomimetic vanadyl complexes in rats by ESR spectroscopy.Pharmacological and toxicological evaluation of Urtica dioica.Individual sulfonylureas and serious hypoglycemia in older people.An evaluation of the therapeutic effects and dosage equivalence of glyburide and glipizide.
P2860
Q24810435-91124C99-7C50-4C60-82FF-8C0681DEC471Q33630129-DE780F76-05FF-4671-AC6E-EF7DFCCA219EQ34163110-42CD9B40-3F87-4B68-99C2-0627710BA112Q34513171-C5812D9C-7465-4B1D-B638-5F6DA4BB8933Q34621645-EE545388-F120-427C-96AC-7AF6A286BBC4Q34992888-34875E3A-0B06-4DA7-98D0-9EB509FFFCEDQ35870633-47B9D1EB-2757-4CDB-89D3-521BB3579ED1Q36322637-25A10684-F65C-48D4-BAD8-538DB97EB0EAQ36531530-D5F55F5C-BA34-4075-BDF6-AEDD51FAE24DQ36830742-7EA8B293-E838-4507-BA9D-6D9F1515A31DQ38190489-913AD322-43A8-4D65-B1FB-69F36D3B3652Q38208811-15F6F074-A1E7-4725-9705-58E9A4127660Q38997095-10861D9B-070F-4082-BB24-E39FF504104BQ39109167-BE295316-09DA-458D-95D2-CC9157C19EEAQ41999957-99FE6C93-8E29-4142-8CD1-35DDAC5CAA2DQ42075123-E13DF8A1-0F92-47E0-9F72-CFD8C560F8B3Q42531562-13C79699-96AF-4373-88A3-A7BD8B0B04CDQ43190955-7AEBF6D4-16AB-4497-9D48-01BC59404082Q43751548-9855D31F-AF51-416A-AEFE-3305C3E4F7CBQ44488194-F64BA8B3-8B09-496E-9C63-922CC2806D5FQ51027313-FC47FA4C-65CE-4316-AE24-6FBD40D36DABQ51617077-4A59294F-6D93-41D1-9CD9-87C32C936E8D
P2860
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
description
1981 nî lūn-bûn
@nan
1981 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1981 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1981年の論文
@ja
1981年論文
@yue
1981年論文
@zh-hant
1981年論文
@zh-hk
1981年論文
@zh-mo
1981年論文
@zh-tw
1981年论文
@wuu
name
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@ast
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@en
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@nl
type
label
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@ast
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@en
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@nl
prefLabel
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@ast
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@en
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@nl
P1433
P1476
Clinical pharmacology of sulphonylurea hypoglycaemic agents: part 1.
@en
P2093
Bressler R
Jackson JE
P304
P356
10.2165/00003495-198122030-00003
P577
1981-09-01T00:00:00Z
P6179
1020174274